Literature DB >> 23249339

Reliability and responsiveness of dynamic contrast-enhanced magnetic resonance imaging in rheumatoid arthritis.

M B Axelsen1, R P Poggenborg, M Stoltenberg, O Kubassova, M Boesen, K Hørslev-Petersen, H Bliddal, L G Hanson, M Østergaard.   

Abstract

OBJECTIVES: To investigate the responsiveness to treatment and the reliability of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in rheumatoid arthritis (RA) knee joints.
METHODS: DCE-MRI was performed in 12 clinically active RA knee joints before and 1, 7, 30, and 180 days after intra-articular injection with 80 mg methylprednisolone. Using semi-automated image processing software, DCE-MRI parameters, including the initial rate of enhancement (IRE) and maximal enhancement (ME), were generated for three regions of interest (ROIs): 'Whole slice', 'Quick ROI', and 'Precise ROI'. The smallest detectable difference (SDD), the smallest detectable change (SDC), and intra- and inter-reader intraclass correlation coefficients (ICCs) were used to assess the reliability of DCE-MRI. Responsiveness to treatment was assessed by the standardized response mean (SRM).
RESULTS: In all patients clinical remission of the knee was achieved at day 7. All DCE-MRI parameters decreased from day 0 to day 7. Using the Quick and Precise ROI methods, respectively, IRE decreased by 63% and 69%, ME decreased by 11% and 11%, N decreased by 55% and 57%, and IRE × N decreased by 84% and 85%. The intra- and inter-reader ICCs were very high (0.96-1.00). The decrease in DCE-MRI parameters was larger than the SDC for all patients. SRM was large for all parameters, ranging from -1.04 to -2.40. When the Whole slice ROI method was used, no parameters were responsive to treatment.
CONCLUSIONS: DCE-MRI analysed using semi-automatic software is a reliable and responsive tool for assessing treatment in RA knees joints. Rough manual delineation of the joint to omit enhancement artefacts is necessary.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23249339     DOI: 10.3109/03009742.2012.723745

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  14 in total

1.  Dynamic contrast-enhanced imaging of the wrist in rheumatoid arthritis: dedicated low-field (0.25-T) versus high-field (3.0-T) MRI.

Authors:  Ryan K L Lee; James F Griffith; D F Wang; L Shi; David K W Yeung; Edmund K Li; L S Tam
Journal:  Skeletal Radiol       Date:  2015-02-27       Impact factor: 2.199

2.  Perfusion in bone marrow lesions assessed on DCE-MRI and its association with pain in knee osteoarthritis: a cross-sectional study.

Authors:  Cecilie L Daugaard; Robert Gc Riis; Elisabeth Bandak; Henrik Gudbergsen; Marius Henriksen; Henning Bliddal; Mikael Boesen
Journal:  Skeletal Radiol       Date:  2019-12-09       Impact factor: 2.199

3.  MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16.

Authors:  M Østergaard; L T H Jacobsson; C Schaufelberger; M Sejer Hansen; J W J Bijlsma; A Dudek; M Rell-Bakalarska; F Staelens; R Haake; B Sundman-Engberg; H Bliddal
Journal:  Ann Rheum Dis       Date:  2014-12-15       Impact factor: 19.103

4.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

5.  Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease.

Authors:  Jianguo Zhu; Faming Zhang; Yun Luan; Peng Cao; Fei Liu; Wenwen He; Dehang Wang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 6.  Selected issues in diagnostic imaging of spondyloarthritides: psoriatic arthritis and juvenile spondyloarthritis.

Authors:  Iwona Sudoł-Szopińska; Mateusz Płaza; Grzegorz Pracoń
Journal:  Reumatologia       Date:  2016-12-30

7.  The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study.

Authors:  Signe Rifbjerg-Madsen; Anton Wulf Christensen; Mikael Boesen; Robin Christensen; Bente Danneskiold-Samsøe; Henning Bliddal; Lene Dreyer; Henning Locht; Kirstine Amris
Journal:  Arthritis Res Ther       Date:  2018-05-30       Impact factor: 5.156

8.  Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.

Authors:  Philip G Conaghan; Mikkel Østergaard; Michael A Bowes; Chunying Wu; Thomas Fuerst; Désirée van der Heijde; Fedra Irazoque-Palazuelos; Oscar Soto-Raices; Pawel Hrycaj; Zhiyong Xie; Richard Zhang; Bradley T Wyman; John D Bradley; Koshika Soma; Bethanie Wilkinson
Journal:  Ann Rheum Dis       Date:  2016-01-25       Impact factor: 19.103

9.  Synovial volume vs synovial measurements from dynamic contrast enhanced MRI as measures of response in osteoarthritis.

Authors:  A D Gait; R Hodgson; M J Parkes; C E Hutchinson; T W O'Neill; N Maricar; E J Marjanovic; T F Cootes; D T Felson
Journal:  Osteoarthritis Cartilage       Date:  2016-03-31       Impact factor: 6.576

10.  Exercise-induced pain changes associate with changes in muscle perfusion in knee osteoarthritis: exploratory outcome analyses of a randomised controlled trial.

Authors:  Elisabeth Bandak; Mikael Boesen; Henning Bliddal; Robert G C Riis; Sabrina Mai Nielsen; Louise Klokker; Cecilie Bartholdy; Janus Damm Nybing; Marius Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2019-10-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.